Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Rommel Mallari"'
Autor:
Rommel Mallari, Edwin Paming
Publikováno v:
JPAIR, Vol 42, Iss 1, Pp 53-62 (2020)
Ang pag-aaral na ito ay isasagawa upang maalaman ang “Isang Pagsisiyasat sa mga Akdang Pampanitikan sa Ikaapat na Antas ng Batsilyer ng Elementarya at Edukasyon sa Paglinang ng mga Pilosopiyang Likas at Pagpapahalagang Moral na Ginagamit sa Pagtutu
Externí odkaz:
https://doaj.org/article/2f1c818850134410a9cb1b86c83d52d4
Autor:
Gwenaella Rescourio, Ana Z. Gonzalez, Salman Jabri, Brian Belmontes, Gordon Moody, Doug Whittington, Xin Huang, Sean Caenepeel, Mario Cardozo, Alan C. Cheng, David Chow, Hannah Dou, Adrie Jones, Ron C. Kelly, Yihong Li, Mike Lizarzaburu, Mei-Chu Lo, Rommel Mallari, Cesar Meleza, Yosup Rew, Scott Simonovich, Daqing Sun, Simon Turcotte, Xuelei Yan, Simon G. Wong, Evelyn Yanez, Manuel Zancanella, Jonathan Houze, Julio C. Medina, Paul E. Hughes, Sean P. Brown
Publikováno v:
Journal of Medicinal Chemistry. 62:10258-10271
Overexpression of the antiapoptotic protein Mcl-1 provides a survival advantage to some cancer cells, making inhibition of this protein an attractive therapeutic target for the treatment of certain types of tumors. Herein, we report our efforts towar
Publikováno v:
SLAS discovery : advancing life sciences RD. 26(2)
Since the revolutionary discovery of RNA interference (RNAi) more than 20 years ago, synthetic small interfering RNAs (siRNAs) have held great promise as therapeutic agents for treating human diseases by the specific knockdown of disease-causing gene
Supplemental material, Supplemental_Material_FISH_Dou_et_al for An Automated High-Throughput Fluorescence In Situ Hybridization (FISH) Assay Platform for Use in the Identification and Optimization of siRNA-Based Therapeutics by Hui H. Dou, Rommel Mal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::090d776c0c91cc7f0f381e150524036d
Publikováno v:
SLAS Discovery. 8:198-204
A generic high-throughput screening assay based on the scintillation proximity assay technology has been developed for protein kinases. In this assay, the biotinylated (33)P-peptide product is captured onto polylysine Ysi bead via avidin. The scintil
Autor:
Ian Foltz, Jennifer J. Kordich, Julia C. Piasecki, Thu Dang, Jonathan David Graves, John M. Rossi, Daniel Branstetter, Tzu-Hsuan Huang, Heather Douangpanya, Timothy J. Sullivan, Alexander M. Long, Wesley Chang, Xiaoning Zhao, Rommel Mallari, Xin Huang, Jason W. O'Neill, Pamela M. Holland, Tammy L. Bush
Publikováno v:
Cancer cell. 26(2)
SummaryDeath receptor agonist therapies have exhibited limited clinical benefit to date. Investigations into why Apo2L/TRAIL and AMG 655 preclinical data were not predictive of clinical response revealed that coadministration of Apo2L/TRAIL with AMG
Autor:
Shu-Chen Lu, Soo Hang Wong, Wei Gu, Paul H. Lee, Melissa Graham, Larissa Atangan, Xiaoning Zhao, Rommel Mallari
Publikováno v:
Assay and drug development technologies. 8(4)
Lysophosphatidic acid (LPA) is a bioactive phospholipid that signals through G-protein-coupled receptors to produce a range of biological responses. A recently reported LPA receptor GPR23 (LPA4 receptor) has a low homology to the LPA(1-3) receptors i
Autor:
Shou-Hua Xiao, Adam Park, Keith R. Olson, Adrie D. Jones, Stephen W. Young, Danilo Nebalasca, Rommel Mallari, Kun Peng, Tom S. Wehrman, Xiaoning Zhao
Publikováno v:
Journal of biomolecular screening. 13(8)
G-protein-coupled receptors (GPCRs) represent one of the largest gene families in the human genome and have long been regarded as valuable targets for small-molecule drugs. The authors describe a new functional assay that directly monitors GPCR activ
Autor:
Soo Hang Wong, Rommel Mallari, Melissa Graham, Larissa Atangan, Shu-Chen Lu, Xiaoning Zhao, Wei Gu, Paul H. Lee
Publikováno v:
Assay & Drug Development Technologies; Aug2010, Vol. 8 Issue 4, p459-470, 12p